Colombian city leads pharma study of treatment for leismaniasis of the skin
Medellin, Colombia, Dec 6 (EFE).- The Ruta N corporation and the Drugs for Neglected Diseases Initiative, or DNDi, are supporting a study in the Colombian city of Medellin aimed at developing a drug...